ArticleeLife2025
Oxytocin restores context-specific hyperaltruistic preference.
Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Recent advances in moral decision-making research show people are hyperaltruistic by being more willing to sacrifice monetary gains to spare others from suffering than to spare themselves. Yet other studies indicate an opposite egoistic bias: subjects are less willing to harm themselves for others' benefits than for their own. These results underscore the complexities of moral decisions and demand a mechanistic explanation for hyperaltruistic preferences. We investigated hyperaltruism using trade-off choices combining monetary gains and painful electric shocks and choices combining monetary losses and shocks. Study 1 revealed that switching the decision context from gains to losses effectively eliminated the hyperaltruistic preference, accompanied by the altered relationship between subjects' instrumental harm (IH) trait attitudes and relative pain sensitivities. In the pre-registered study 2, we found that oxytocin, a neuropeptide linked to parochial altruism, restored the context-dependent hyperaltruistic preference. Furthermore, oxytocin increased the degree to which subjects framed the task as harming others, which mediated the correlation between IH and relative pain sensitivities. Thus, the loss decision context and oxytocin diminished and restored the mediation effect of subjective harm framing, respectively. Our results help elucidate the psychological processes underpinning the contextual specificity of hyperaltruism and carry implications in promoting prosocial interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.